WST · West Pharmaceutical Services, Inc.
$254.802026-05-17Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$129
-49.4% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($123 · $149) Analysts Range ($265 · $340) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $2.8B | — | 26.8% | 13.9% | $653MM | −$327MM | $326MM | 8.3% | — | 35.6% | $1.8B | $9.10 | — |
| 2022.Q4 | $2.9B | 1.9% | 26.5% | 16.4% | $639MM | −$175MM | $463MM | 9.2% | — | 33.2% | $2.0B | $8.06 | — |
| 2023.Q4 | $3.0B | 2.3% | 24.1% | 17.1% | $589MM | −$245MM | $344MM | 8.8% | — | 27.6% | $2.3B | $8.16 | — |
| 2024.Q4 | $2.9B | -2.0% | 20.6% | 17.9% | $488MM | −$219MM | $269MM | 9.5% | — | 20.9% | $2.4B | $6.78 | — |
| 2025.Q4 | $3.1B | 6.3% | 20.1% | 19.8% | $495MM | −$50MM | $445MM | 9.5% | — | 19.7% | $2.6B | $6.79 | 30.0 |
| italics below = DCF projection · 10yr Rev CAGR: 5.5% |
| 2026.Q4 | $3.2B | +5.7% | 20.1% | 19.8% | $525MM | −$79MM | $446MM | 9.2% | $409MM | 19.8% | $2.7B | $7.22 | 35.3 |
| 2027.Q4 | $3.5B | +6.3% | 20.1% | 19.8% | $558MM | −$108MM | $450MM | 9.1% | $377MM | 20.3% | $2.8B | $7.67 | 33.2 |
| 2028.Q4 | $3.7B | +7.1% | 20.1% | 19.8% | $597MM | −$160MM | $437MM | 9.1% | $336MM | 20.8% | $3.0B | $8.21 | 31.0 |
| 2029.Q4 | $3.9B | +6.3% | 20.1% | 19.9% | $635MM | −$193MM | $441MM | 9.0% | $312MM | 20.8% | $3.1B | $8.73 | 29.2 |
| 2030.Q4 | $4.2B | +5.9% | 20.1% | 19.9% | $672MM | −$195MM | $477MM | 9.0% | $309MM | 20.7% | $3.3B | $9.24 | 27.6 |
|
| Term. Yr+ | $5.5B | 4.1% | 17.7% | 20.0% | $779MM | −$175MM | $603MM | 8.6% | $5.7B | 18.2% | — | — | — |
Active scenario IV: $129 (-49.4% vs market)